Sign in
CompletedNo phase

Objective Measurements of the Opacification of the Lens After Vitrectomy

Key facts

Who runs it
Fondation Ophtalmologique Adolphe de Rothschild
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
44 people enrolled
Started
21 Sept 2020
Ended
12 Dec 2024
Type of study
Interventional
Treatments tested
  • Objective Scatter Index (OSI)
  • Average Lens Density (ALD)
Record updated
13 February 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patient over 18 years old
  • Indication for unilateral 3-way vitrectomy for retinal detachment, macular hole, epiretinal membrane, vitreous hemorrhage
  • Bilateral phakic patient

Who cannot take part

  • Vitrectomy combined with cataract surgery
  • Pregnant or breastfeeding woman

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Cataract is the opacification of the lens. Usually cataract occurs slowly, causing progressive vision loss over several months or years.

Read full original descriptionShow less

In ophthalmic clinical practice, repeated objective quantitative measurements of lens opacity may be necessary to document its progression and support a surgical indication.

The subjective methods of evaluating the opacification of the lens have limitations, in particular due to the lack of reproducibility between observers. Thus, innovative objective techniques with precise and reproducible cataract classification results have been developed, such as the Objective Scatter Index (OSI) on the Optical Quality Analysis System (OQAS), Visiometrics SL in 2010 and, more recently, Average Lens Density (ALD) on the IOLMaster® 700 device. Cataract is diagnosed as mature when the OSI is ≥ 2 and / or when the ALD is ≥ 74 pixel units.

Vitrectomy is a surgery of the posterior segment of the eye indicated for retinal detachment, epimacular membranes, macular holes, vitreous hemorrhage. The incidence of post-vitrectomy cataract varies among studies, and the methodology is often retrospective. Age has already been identified as a risk factor for progression since in a study of 28 eyes of patients under 50 years old, only 7% developed cataracts secondarily, compared to 79% in the 'over 50' group.

To date, there is no prospective study describing the progression kinetics of lens opacification according to precise and reproducible quantitative objective criteria in patients treated by vitrectomy. It also involves confirming the age and preoperative lens status as a risk factor for postoperative cataract progression.

The group in the trial

  • 24 months follow up after vitrectomyTreatment being tested

    Objective Scatter Index (OSI) and Average Lens Density (ALD) at inclusion, then 3 months, 12 months and 24 months after vitrectomy

    Treatment: Objective Scatter Index (OSI) and Average Lens Density (ALD)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
13 February 2025